Bone Biologics Corp is a healthcare solutions provider based in the United States. As a biotechnology firm, it engages its efforts in developing therapeutics to aid bone regeneration. The company's portfolio comprises its lead product, NELL-1, which is a bone void filler. Bone Biologics' technology has applications in the surgical specialties of spinal, orthopedic, general orthopedic, plastic reconstruction, neurosurgery, interventional radiology, and sports medicine.

$2.5M

Market Cap • 1/29/2025

2007

(18 years)
Founded

2015

(10 years ago)
IPO

NASDAQ

Listing Exchange
Flag of US

Burlington

Headquarters • Massachusetts